News

The data, presented by Merck/Schering-Plough at the International Symposium on Atherosclerosis meeting in Rome, show that Vytorin was more effective than Crestor across all study dose comparisons, 52-61%

Biotechnology company Amgen presented the data at the European Society of Cardiology-Heart Failure Congress. Approximately 20 to 30% of people diagnosed with heart failure also suffer from anemia,

Data from this study demonstrated that treatment with eltrombopag resulted in a significant increase in platelet count compared to placebo across a variety of typically poorly responding idiopathic

The trial is specifically evaluating the safety and tolerability of a continuous infusion of MT103 over a 4- to 8-week period at escalating dose levels. The data were

According to the company, these two disease conditions may represent a continuum in malignant progression of the abnormal production of blood cells in the bone marrow that results

Discovery of the PLA2G6 gene, whose mutated forms trigger several genetic disorders categorized as neuroaxonal dystrophies, could also shed light on the nerve cell degeneration that leads to

Data from the ongoing study indicate that the combination regimen, known as VELSAM, was well tolerated at doses studied to date and demonstrated anti-tumor activity, with 50% of

The researchers found that almost two-thirds of patients with REM sleep behavior disorder (RBD) develop degenerative brain diseases by approximately 11 years after diagnosis of RBD. “Hopefully, early

Vaccines based on this model might therefore be suitable for stockpiling for use during a pandemic until a new vaccine could be developed specifically against the variant causing